Clinical Trial Update: Vaginal Estrogen for Asymptomatic Microscopic Hematuria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update sponsored by Boston Urogynecology Associates evaluating vaginal estrogen for asymptomatic microscopic hematuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asymptomatic Microscopic Hematuria

Drugs mentioned

• Vaginal estrogen

Snippet

Sponsor: Boston Urogynecology Associates | Conditions: Asymptomatic Microscopic Hematuria | Phase 4 | Status: UNKNOWN